FDA Approved: ZOLYMBUS — Original Application (Thea Pharma Inc.)

View source ↗

Summary

FDA approved ZOLYMBUS (bimatoprost) from Thea Pharma Inc. under NDA217307 as an ocular hypotensive agent to lower intraocular pressure in adults with open-angle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ZOLYMBUS (BIMATOPROST)

Snippet

ORIG AP for ZOLYMBUS (BIMATOPROST)